SECTOR:
CNS
FUND/VEHICLE:
NFLS Direct Investment
INVESTMENT DATE:
2018
GEOGRAPHY:
North America
STATUS CURRENT/FORMER INVESTMENT:
Existing
WEBSITE:
Navitor’s mission is to discover and develop a new class of medicines that restore normal activity to mTORC1 to treat age-related diseases and improve human health.